Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NUF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ANKRD20A11P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
NOP16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
AKR1C6P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
JPX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GSK3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01225 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF157 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDFY3-AS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCAF13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR61 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL13AP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CUTC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HNRNPDL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01315 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANAPC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on